RedCarpetLife
Billionaires
Business
Luxury Lifestyle
Lists
World Leaders
Fashion & Style
Tools
Featured Articles
Learn Finance with Arthalogy
Advertise with RedCarpetLife
Contact Us
Careers at RedCarpetLife
Meet Our Authors
About Us
Correction or Feedback
Terms of Use
Privacy Policy
2599
In the world today
Ye Xiaoping

Ye Xiaoping

Y. Xiaoping
0.28% | + $4.08M
$1.47 B ₹ 13,789 Cr
Real Time Net Worth #2599 Ranking as of 21 Mar 2026 By Forbes
Check Your Ranking

More on Ye Xiaoping

Gender

Male

Age

63Y

Country

China

Born On

January, 1963

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

University Of Oxford - PhD

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Healthcare)

Primary Organization

Hangzhou Tigermed Consulting

Titles

Founder & Chairman

Sources of Wealth

Pharmaceutical Services

Industry

Healthcare, Service

About Ye Xiaoping

Y e Xiaoping is the founder and chairman of Hangzhou Tigermed Consulting, China's leading contract research organization (CRO) for clinical trials. A highly educated scientist with a PhD from Oxford University and an EMBA from Peking University, Ye spent years working as a medical director for Roche in China. He identified a gap in the domestic market for high-quality clinical trial services and founded Tigermed in 2004 to bridge it.

Under his leadership, Tigermed has become the go-to partner for both multinational and domestic pharmaceutical companies seeking to navigate China's complex drug approval process. The company listed on the Shenzhen Stock Exchange in 2012 and later in Hong Kong. Ye has aggressively expanded Tigermed's global footprint through acquisitions in the US and Europe, establishing it as a key player in the global drug development ecosystem.

Advertisement

Quick Reads

Early Life and Background

Ye Xiaoping is a Chinese businessman, the chairman of Hangzhou Tigermed Consulting (HKSE: 3347 / SZSE: 300347), one of China's largest contract research organizations (CRO) in the pharmaceutical industry.

Ye holds an EMBA from Peking University and a Ph.D. from Oxford University. He was an executive at Swiss pharmaceutical giant Roche before becoming an entrepreneur and founding Tigermed in 2004.

  • Core Company: Hangzhou Tigermed Consulting (Contract research organization).
  • Founding: Founded in 2004.
  • Education: Holds a Ph.D. from Oxford University and an EMBA from Peking University.

Career Journey of Ye Xiaoping

Ye Xiaoping's career is defined by his extensive international experience and his successful move into entrepreneurship. His structural achievement is tied to establishing Tigermed as one of China's largest contract research organizations, filling a critical need in the rapidly developing Chinese pharmaceutical industry.

His prior experience as an executive at Swiss pharmaceutical giant Roche provided the strategic understanding of the global drug development process.

  • Prior Role: Executive at Swiss pharmaceutical giant Roche.

Advertisement

Ye Xiaoping's Timeline

Pre-2004:

Was an executive at Swiss pharmaceutical giant Roche.

2004:

Tigermed was founded.

Ongoing:

Continues as Chairman.

Major Business Ventures and Investments

Ye Xiaoping's wealth is concentrated in his founding equity and continued leadership of the publicly traded healthcare giant, Hangzhou Tigermed Consulting.

  • Hangzhou Tigermed Consulting (Chairman): One of China's largest contract research organizations.
  • Education: Holds a Ph.D. from Oxford University.
  • Sector Focus: Pharmaceutical contract research, clinical trials, and biotechnology services.

Advertisement

Philanthropy and Social Impact

Fashion, Style, and Lifestyle

Advertisement

Quotes and Philosophy

No publicly available quotes.

Fun Facts & Trivia

  • He is the chairman of Hangzhou Tigermed Consulting, one of China's largest contract research organizations.
  • He holds a Ph.D. from Oxford University and an EMBA from Peking University.
  • He was an executive at Swiss pharmaceutical giant Roche before becoming an entrepreneur.

Advertisement

More Profiles

Bernard Saul II & family

Bernard Saul II & family

#1512

-0.06% | -$1.50M

John Catsimatidis

John Catsimatidis

#858

+6.88% | +$310.00M

You May Like

Sources & References

This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content